Home Markets Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Jun 17, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/eli-lilly-nears-13-billion-deal-for-geneediting-biotech-verve-therapeutics-ft-reports-4098210

You May Also Like

Boring Company valuation hits $20 billion in latest funding round – WSJ

Howmet’s SpaceX threat looks more like a buying opportunity: Bernstein

Seattle Times, Newsday sue OpenAI, Microsoft, alleging copyright infringement

Exclusive-Anthropic IPO launch shifts toward mid-October, sources say

Starbucks anti-unionization case brought by NLRB narrowed by US appeals court

AI hiring boom could turn into a surprise tailwind for software: Bernstein